Cargando…
Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors
SIMPLE SUMMARY: Liquid biopsy of cell-free DNA (cfDNA) is proposed as potential method for the early detection of breast cancer (BC) metastases and following the clonal evolution of BC. Though the use of liquid biopsy is widely discussed, only few studies have demonstrated such usage so far. The aim...
Autores principales: | Kujala, Jouni, Hartikainen, Jaana M., Tengström, Maria, Sironen, Reijo, Auvinen, Päivi, Kosma, Veli-Matti, Mannermaa, Arto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909912/ https://www.ncbi.nlm.nih.gov/pubmed/35267640 http://dx.doi.org/10.3390/cancers14051332 |
Ejemplares similares
-
High mutation burden of circulating cell‐free DNA in early‐stage breast cancer patients is associated with a poor relapse‐free survival
por: Kujala, Jouni, et al.
Publicado: (2020) -
High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival
por: Lamminaho, Maria, et al.
Publicado: (2021) -
Predicting breast cancer risk using interacting genetic and demographic factors and machine learning
por: Behravan, Hamid, et al.
Publicado: (2020) -
Transcription factors zeb1, twist and snai1 in breast carcinoma
por: Soini, Ylermi, et al.
Publicado: (2011) -
The debatable presence of PIWI‐interacting RNAs in invasive breast cancer
por: Kärkkäinen, Emmi, et al.
Publicado: (2021)